U.S., Jan. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07320521) titled 'A Study to Assess the Mass Balance of [14C]HRS-8080 in Healthy Chinese Postmenopausal Female Subjects.' on Dec. 22, 2025.
Brief Summary: This single-part, healthy volunteer study will try to identify how the test medicine is taken up, broken down and removed from the body. To help investigate this, the test medicine is radiolabelled, which means that the test medicine has a radioactive component (carbon-14) which helps us to track where the test medicine is in the body. The safety and tolerability of the test medicine will also be studied.
Study Start Date: Jan., 2026
Study Type: INTERVENTIONAL
Condition:
Breast Cancer
Intervent...